Search

Search Constraints

You searched for: Author/Creator Kawabata, I.

Search Results

1. An extended phase Ib study of epertinib, an orally active reversible dual EGFR/HER2 tyrosine kinase inhibitor, in patients with solid tumours. (November 2018)

3. OP27.07: The accuracy of diagnosing placenta previa on transvaginal ultrasound at 20–24 weeks' gestation by distinguishing between the uterine isthmus and cervix. (September 2016)

6. P21.11: Decrease of human chorionic gonadotropin (hCG) in the cases of fetal pleural effusion following effective thoraco‐amniotic shunting (TAS). (September 2014)

7. Phase 1 dose-escalation study of S-222611, an oral reversible dual tyrosine kinase inhibitor of EGFR and HER2, in patients with solid tumours. Issue 2 (January 2015)